YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway

Abstract Radiotherapy is an important strategy in the comprehensive treatment of esophageal squamous cell carcinoma (ESCC). However, effectiveness of radiotherapy is still restricted by radioresistance. Herein, we aimed to understand the mechanisms underlying ESCC radioresistance, for which we looke...

Full description

Bibliographic Details
Main Authors: Chunyan Zheng, Zhe Li, Chuanxi Zhao, Xiaoyang Yin, Lei Feng, Zhongtang Wang, Chengxin Liu, Baosheng Li
Format: Article
Language:English
Published: Nature Publishing Group 2023-12-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-023-06321-x
_version_ 1797397763055419392
author Chunyan Zheng
Zhe Li
Chuanxi Zhao
Xiaoyang Yin
Lei Feng
Zhongtang Wang
Chengxin Liu
Baosheng Li
author_facet Chunyan Zheng
Zhe Li
Chuanxi Zhao
Xiaoyang Yin
Lei Feng
Zhongtang Wang
Chengxin Liu
Baosheng Li
author_sort Chunyan Zheng
collection DOAJ
description Abstract Radiotherapy is an important strategy in the comprehensive treatment of esophageal squamous cell carcinoma (ESCC). However, effectiveness of radiotherapy is still restricted by radioresistance. Herein, we aimed to understand the mechanisms underlying ESCC radioresistance, for which we looked into the potential role of YY1. YY1 was upregulated in radioresistant tissues and correlated with poor prognosis of patients with ESCC. YY1 depletion enhanced the radiosensitivity of ESCC in vitro and in vivo. Multi-group sequencing showed that downregulation of YY1 inhibited the transcriptional activity of Kinesin Family Member 3B (KIF3B), which further activated the Hippo signaling pathway by interacting with Integrin-beta1 (ITGB1). Once the Hippo pathway was activated, its main effector, Yes-associated protein 1 (YAP1), was phosphorylated in the cytoplasm and its expression reduced in the nucleus, thus enhancing the radiosensitivity by regulating its targeted genes. Our study provides new insights into the mechanisms underlying ESCC radioresistance and highlights the potential role of YY1 as a therapeutic target for ESCC.
first_indexed 2024-03-09T01:14:50Z
format Article
id doaj.art-9a984369bd25496599fc9890cc717253
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-03-09T01:14:50Z
publishDate 2023-12-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-9a984369bd25496599fc9890cc7172532023-12-10T12:33:27ZengNature Publishing GroupCell Death and Disease2041-48892023-12-01141211210.1038/s41419-023-06321-xYY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathwayChunyan Zheng0Zhe Li1Chuanxi Zhao2Xiaoyang Yin3Lei Feng4Zhongtang Wang5Chengxin Liu6Baosheng Li7Shandong First Medical University and Shandong Academy of Medical SciencesDepartment of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Clinical Laboratory, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical SciencesDepartment of Radiation Oncology, The Affiliated Hospital of Qingdao UniversityDepartment of Radiation Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical SciencesDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical SciencesShandong First Medical University and Shandong Academy of Medical SciencesAbstract Radiotherapy is an important strategy in the comprehensive treatment of esophageal squamous cell carcinoma (ESCC). However, effectiveness of radiotherapy is still restricted by radioresistance. Herein, we aimed to understand the mechanisms underlying ESCC radioresistance, for which we looked into the potential role of YY1. YY1 was upregulated in radioresistant tissues and correlated with poor prognosis of patients with ESCC. YY1 depletion enhanced the radiosensitivity of ESCC in vitro and in vivo. Multi-group sequencing showed that downregulation of YY1 inhibited the transcriptional activity of Kinesin Family Member 3B (KIF3B), which further activated the Hippo signaling pathway by interacting with Integrin-beta1 (ITGB1). Once the Hippo pathway was activated, its main effector, Yes-associated protein 1 (YAP1), was phosphorylated in the cytoplasm and its expression reduced in the nucleus, thus enhancing the radiosensitivity by regulating its targeted genes. Our study provides new insights into the mechanisms underlying ESCC radioresistance and highlights the potential role of YY1 as a therapeutic target for ESCC.https://doi.org/10.1038/s41419-023-06321-x
spellingShingle Chunyan Zheng
Zhe Li
Chuanxi Zhao
Xiaoyang Yin
Lei Feng
Zhongtang Wang
Chengxin Liu
Baosheng Li
YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway
Cell Death and Disease
title YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway
title_full YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway
title_fullStr YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway
title_full_unstemmed YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway
title_short YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway
title_sort yy1 modulates the radiosensitivity of esophageal squamous cell carcinoma through kif3b mediated hippo signaling pathway
url https://doi.org/10.1038/s41419-023-06321-x
work_keys_str_mv AT chunyanzheng yy1modulatestheradiosensitivityofesophagealsquamouscellcarcinomathroughkif3bmediatedhipposignalingpathway
AT zheli yy1modulatestheradiosensitivityofesophagealsquamouscellcarcinomathroughkif3bmediatedhipposignalingpathway
AT chuanxizhao yy1modulatestheradiosensitivityofesophagealsquamouscellcarcinomathroughkif3bmediatedhipposignalingpathway
AT xiaoyangyin yy1modulatestheradiosensitivityofesophagealsquamouscellcarcinomathroughkif3bmediatedhipposignalingpathway
AT leifeng yy1modulatestheradiosensitivityofesophagealsquamouscellcarcinomathroughkif3bmediatedhipposignalingpathway
AT zhongtangwang yy1modulatestheradiosensitivityofesophagealsquamouscellcarcinomathroughkif3bmediatedhipposignalingpathway
AT chengxinliu yy1modulatestheradiosensitivityofesophagealsquamouscellcarcinomathroughkif3bmediatedhipposignalingpathway
AT baoshengli yy1modulatestheradiosensitivityofesophagealsquamouscellcarcinomathroughkif3bmediatedhipposignalingpathway